X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with ASTRAZENECA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ASTRAZENECA PHARMA - Comparison Results

ASTRAZENECA PHARMA 
   Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS ASTRAZENECA PHARMA DR. DATSONS LABS/
ASTRAZENECA PHARMA
 
P/E (TTM) x -10.9 401.7 - View Chart
P/BV x 0.2 19.7 0.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DR. DATSONS LABS   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ASTRAZENECA PHARMA
Mar-14
DR. DATSONS LABS/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs1261,285 9.8%   
Low Rs31634 4.9%   
Sales per share (Unadj.) Rs133.0189.6 70.1%  
Earnings per share (Unadj.) Rs0.2-0.2 -74.5%  
Cash flow per share (Unadj.) Rs6.63.8 171.9%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.868.6 187.6%  
Shares outstanding (eoy) m31.6625.00 126.6%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.65.1 11.6%   
Avg P/E ratio x516.1-4,712.7 -11.0%  
P/CF ratio (eoy) x11.8249.6 4.7%  
Price / Book Value ratio x0.614.0 4.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,47723,988 10.3%   
No. of employees `000NA1.6 0.0%   
Total wages/salary Rs m561,605 3.5%   
Avg. sales/employee Rs ThNM3,040.2-  
Avg. wages/employee Rs ThNM1,029.2-  
Avg. net profit/employee Rs ThNM-3.3-  
INCOME DATA
Net Sales Rs m4,2114,740 88.8%  
Other income Rs m7992 85.5%   
Total revenues Rs m4,2894,832 88.8%   
Gross profit Rs m569-130 -438.1%  
Depreciation Rs m204101 202.0%   
Interest Rs m4300-   
Profit before tax Rs m13-139 -9.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0139 0.0%   
Tax Rs m65 119.8%   
Profit after tax Rs m5-5 -94.3%  
Gross profit margin %13.5-2.7 -493.1%  
Effective tax rate %48.0-3.7 -1,310.7%   
Net profit margin %0.1-0.1 -106.2%  
BALANCE SHEET DATA
Current assets Rs m6,8522,726 251.3%   
Current liabilities Rs m6,7112,435 275.6%   
Net working cap to sales %3.36.1 54.5%  
Current ratio x1.01.1 91.2%  
Inventory Days Days16174 218.1%  
Debtors Days Days31841 781.3%  
Net fixed assets Rs m3,6731,035 354.8%   
Share capital Rs m31750 633.2%   
"Free" reserves Rs m3,761942 399.1%   
Net worth Rs m4,0781,716 237.6%   
Long term debt Rs m1,6710-   
Total assets Rs m12,6334,156 304.0%  
Interest coverage x1.0NM-  
Debt to equity ratio x0.40-  
Sales to assets ratio x0.31.1 29.2%   
Return on assets %3.4-0.1 -2,811.6%  
Return on equity %0.1-0.3 -39.7%  
Return on capital %7.70-  
Exports to sales %22.95.7 401.6%   
Imports to sales %14.36.5 221.2%   
Exports (fob) Rs m964270 356.8%   
Imports (cif) Rs m602306 196.5%   
Fx inflow Rs m964375 257.3%   
Fx outflow Rs m607470 129.1%   
Net fx Rs m357-96 -373.5%   
CASH FLOW
From Operations Rs m1,345-8 -16,602.5%  
From Investments Rs m-2,256-146 1,548.1%  
From Financial Activity Rs m-1,200862 -139.2%  
Net Cashflow Rs m-2,111709 -297.9%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 0.3 -  
FIIs % 1.4 15.7 8.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 9.1 1,034.1%  
Shareholders   20,807 12,856 161.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   STERLING BIOTECH  PFIZER  ALEMBIC PHARMA  ORCHID PHARMA LTD  SANOFI INDIA  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 190 Points Higher; Consumer Durable and Healthcare Stocks Witness Buying(Closing)

After trimming sharp losses in the afternoon session, Indian share markets continued to witness buying interest and ended the day on a positive note.

Related Views on News

ASTRAZENECA PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 66.7% (Quarterly Result Update)

Nov 27, 2018 | Updated on Nov 27, 2018

For the quarter ended September 2018, ASTRAZENECA PHARMA has posted a net profit of Rs 91 m (down 66.7% YoY). Sales on the other hand came in at Rs 2 bn (down 1.8% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 10.3% (Quarterly Result Update)

Aug 21, 2018 | Updated on Aug 21, 2018

For the quarter ended June 2018, ASTRAZENECA PHARMA has posted a net profit of Rs 64 m (up 10.3% YoY). Sales on the other hand came in at Rs 2 bn (up 25.7% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS